Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott D Solomon

Showing results (551-560 of 1,211) with videos related to

Pageof 122
Sort By:
Diabetes, Obesity & Metabolism|July 8, 2022
Re-examining the widespread policy of stopping sodium-glucose cotransporter-2 inhibitors during acute illness: A perspective based on the updated evidenceKamlesh Khunti, Vanita R Aroda, Deepak L Bhatt, et al.
Journal of the American College of Cardiology|May 3, 2002
Right ventricular dysfunction and risk of heart failure and mortality after myocardial infarctionLeonardo A M Zornoff, Hicham Skali, Marc A Pfeffer, et al.
European Journal of Heart Failure|October 2, 2015
Increased risk of stroke with darbepoetin alfa in anaemic heart failure patients with diabetes and chronic kidney diseaseNatalie A Bello, Eldrin F Lewis, Akshay S Desai, et al.
European Heart Journal|December 5, 2013
Left atrial structure and function in atrial fibrillation: ENGAGE AF-TIMI 48Deepak K Gupta, Amil M Shah, Robert P Giugliano, et al.
European Heart Journal|October 30, 2013
Left ventricular dyssynchrony in patients with heart failure and preserved ejection fractionAngela B S Santos, Elisabeth Kraigher-Krainer, Natalie Bello, et al.
Circulation. Heart Failure|November 20, 2013
Cardiac structure and function in heart failure with preserved ejection fraction: baseline findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist trialAmil M Shah, Sanjiv J Shah, Inder S Anand, et al.
JACC. Advances|June 28, 2024
Effects of Sacubitril/Valsartan vs Valsartan in De Novo vs Acute on Chronic HFpEF and HFmrEFEvan M Murray, Derek Cyr, Marat Fudim, et al.
European Journal of Heart Failure|October 9, 2020
Left ventricular systolic ejection time is an independent predictor of all-cause mortality in heart failure with reduced ejection fractionAlia S Alhakak, Morten Sengeløv, Peter G Jørgensen, et al.
European Heart Journal. Acute Cardiovascular Care|January 17, 2023
Trajectory and correlates of pulmonary congestion by lung ultrasound in patients with acute myocardial infarction: insights from PARADISE-MIElke Platz, Brian Claggett, Karola S Jering, et al.
European Journal of Heart Failure|February 10, 2021
Dynamic changes in cardiovascular and systemic parameters prior to sudden cardiac death in heart failure with reduced ejection fraction: a PARADIGM-HF analysisLuis E Rohde, Muthiah Vaduganathan, Brian L Claggett, et al.
Pageof 122

Showing results (551-560 of 1,211) with videos related to

Sort By:
Pageof 122
Diabetes, Obesity & Metabolism|July 8, 2022
Re-examining the widespread policy of stopping sodium-glucose cotransporter-2 inhibitors during acute illness: A perspective based on the updated evidenceKamlesh Khunti, Vanita R Aroda, Deepak L Bhatt, et al.
Journal of the American College of Cardiology|May 3, 2002
Right ventricular dysfunction and risk of heart failure and mortality after myocardial infarctionLeonardo A M Zornoff, Hicham Skali, Marc A Pfeffer, et al.
European Journal of Heart Failure|October 2, 2015
Increased risk of stroke with darbepoetin alfa in anaemic heart failure patients with diabetes and chronic kidney diseaseNatalie A Bello, Eldrin F Lewis, Akshay S Desai, et al.
European Heart Journal|December 5, 2013
Left atrial structure and function in atrial fibrillation: ENGAGE AF-TIMI 48Deepak K Gupta, Amil M Shah, Robert P Giugliano, et al.
European Heart Journal|October 30, 2013
Left ventricular dyssynchrony in patients with heart failure and preserved ejection fractionAngela B S Santos, Elisabeth Kraigher-Krainer, Natalie Bello, et al.
Circulation. Heart Failure|November 20, 2013
Cardiac structure and function in heart failure with preserved ejection fraction: baseline findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist trialAmil M Shah, Sanjiv J Shah, Inder S Anand, et al.
JACC. Advances|June 28, 2024
Effects of Sacubitril/Valsartan vs Valsartan in De Novo vs Acute on Chronic HFpEF and HFmrEFEvan M Murray, Derek Cyr, Marat Fudim, et al.
European Journal of Heart Failure|October 9, 2020
Left ventricular systolic ejection time is an independent predictor of all-cause mortality in heart failure with reduced ejection fractionAlia S Alhakak, Morten Sengeløv, Peter G Jørgensen, et al.
European Heart Journal. Acute Cardiovascular Care|January 17, 2023
Trajectory and correlates of pulmonary congestion by lung ultrasound in patients with acute myocardial infarction: insights from PARADISE-MIElke Platz, Brian Claggett, Karola S Jering, et al.
European Journal of Heart Failure|February 10, 2021
Dynamic changes in cardiovascular and systemic parameters prior to sudden cardiac death in heart failure with reduced ejection fraction: a PARADIGM-HF analysisLuis E Rohde, Muthiah Vaduganathan, Brian L Claggett, et al.
Pageof 122